Stay updated on Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page.

Latest updates to the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a small page update or fix rather than changes to study details.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's revision label changed from v3.6.4 to v3.6.5, indicating a newer version of the page.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a minor administrative update to the page version.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page shows an updated revision label from v3.6.2 to v3.6.3.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision tag v3.6.2 appears and the older v3.6.0 tag is removed, indicating a small update to the page's version history.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label. The recruitment status is updated to No longer looking for participants, and the revision tag changes from v3.5.5 to v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat Combo with Pembrolizumab in Sarcoma Clinical Trial page.